References

1. K. Krümmerer, Ed., Pharmaceuticals in the Environment: Sources, Fate, Effects, and Risks, 3rd ed., Springer, Berlin, 2008.
2. K. Krümmerer, The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges, J. Environ. Manage., 90 (2009) 2354–2366.
3. D. Taylor, T. Senac, Human pharmaceutical products in the environment - the “problem” in perspective, Chemosphere, 115 (2014) 95–100.
4. W.C. Li, Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil, Environ. Pollut., 187 (2014) 193–201.
5. L. Cizmas, V.K. Sharma, C.M. Gray, T.J. McDonald, Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk, Environ. Chem. Lett., 13 (2015) 381–394.
6. S.C. Weng, P. Sun, W. Ben, C.H. Huang, L.T. Lee, E.R. Blatchely, The presence of pharmaceuticals and personal care products in swimming pools, Environ. Sci. Technol. Lett., 12 (2014) 495−498.
7. T.L. Teo, H.M. Coleman., S.J. Khan, Occurrence and daily variability of pharmaceuticals and personal care products in swimming pools, Environ. Sci. Pollut. Res., 23 (2016) 6972–6981.
8. Y. Ekowati, G. Buttiglieri, G. Ferrero, J. Valle-Sistac, M.S. Diaz- Cruz, D. Barceló, M. Petrovic, M. Villagrasa, M.D. Kennedy, I. Rodríguez-Roda, Occurrence of pharmaceuticals and UV filters in swimming pools and spas, Environ. Sci. Pollut. Res. Int., 23 (2016) 14431–14441.
9. L.M. Suppes, C.H. Huang, W.N. Lee, K.J. Brockman, Sources of pharmaceuticals and personal care products in swimming pools, J. Water Health, 15 (2017) 829–833.
10. A.P. Dufour, O. Evans, T.D. Behymer, R. Cantú, Water ingestion during swimming activities in a pool: a pilot study, J. Water Health, 4 (2006) 425–430.
11. F.A. Caliman, M. Gavrilescu, Pharmaceuticals, personal care products and endocrine disrupting agents in the environment-a review, Clean Soil Air Water, 37 (2009) 277–303.
12. T.A. Ternes, M. Meisenheimer, D. McDowell, F. Sacher, H.-J. Brauch, B. Haist-Gulde, G. Preuss, U. Wilme, N. Zulei-Seibert, Removal of pharmaceuticals during drinking water treatment, Environ. Sci. Technol., 36 (2002) 3855–3863.
13. L.K. Blackstock, W. Wang, S. Vemula, B.T. Jaeger, X.-F. Li, Sweetened Swimming Pools and Hot Tubs, Environ. Sci. Technol. Lett., 4 (2017) 149–153.
14. P. Dalkmann, et al., Accumulation of pharmaceuticals, enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in Central Mexico, PLoS One, 7 (2012) e45397.
15. T.L. Teo, H.M. Coleman, S.J. Khan, Chemical contaminants in swimming pools: occurrence, implications and control, Environ. Int., 76 (2015) 16–31.
16. P. Bottoni, L. Bonadonna, S. Caroli, G. Zaray, Emerging issues on degradation by-products deriving from personal care products and pharmaceuticals during disinfection processes of water used in swimming pools, Microchem. J., 112 (2014) 13–16.
17. A. Zhang, Y. Li, Y. Song, J. Lv, J. Yang, Characterization of pharmaceuticals and personal care products as N-nitrosodimethylamine precursors during disinfection processes using free chlorine and chlorine dioxide, J. Hazard. Mater., 276 (2014) 499–509.
18. R. Shen, S.A. Andrews, Demonstration of 20 pharmaceuticals and personal care products (PPCPs) as nitrosamine precursors during chloramine disinfection, Water Res., 45 (2011) 944–952.
19. S.T. Glassmeyer, A. Shoemaker, Effects of chlorination on the persistence of pharmaceuticals in the environment, Bull. Environ. Contam. Toxicol., 74 (2005) 24–31.
20. K. Kawabata, K. Sugihara, S. Sanoh, S. Kitamura, S. Ohta, Photodegradation of pharmaceuticals in the aquatic environment by sunlight and UV-A, -B and -C irradiation, J. Toxicol. Sci., 38 (2013) 215–223.
21. A.B. Boxall, M.A. Rudd, B.W. Brooks, D.J. Caldwell, K. Choi, S. Hickmann, E. Innes, K. Ostapyk, J.P. Staveley, T. Verslycke, G.T. Ankley, K.F. Beazley, S.E. Belanger, J.P. Berninger, P. Carriquiriborde, A. Coors, P.C. Deleo, S.D. Dyer, J.F. Ericson, F. Gagné, J.P. Giesy, T. Gouin, L. Hallstrom, M.V. Karlsson, D.G. Larsson, J.M. Lazorchak, F. Mastrocco, A. McLaughlin, M.E. McMaster, R.D. Meyerhoff, R. Moore, J.L. Parrott, J.R. Snape, R. Murray-Smith, M.R. Servos, P.K. Sibley, J.O. Straub, N.D. Szabo, E. Topp, G.R. Tetreault, V.L. Trudeau, G. Van Der Kraak, Pharmaceuticals and personal care products in the environment: what are the big questions?, Environ. Health Perspect., 12 (2012) 1221–1229.
22. J.M. Brausch, K.A. Connors, B.W. Brooks, G.M. Rand, Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing, Rev. Environ. Contam. Toxicol., 218 (2012) 1–99.
23. L.H. Santos, A.N. Araújo, A. Fachini, A. Pena, C. Delerue- Matos, M.C. Montenegro, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175 (2010) 45–95.
24. A. Lempart, E. Kudlek, M. Dudziak, Identification of New Groups of Micropollutants in Swimming Pool Water, J. Kulczycka, Ed., Young Researchers’ Innovative Ideas: Science Start-Ups in the Industry, Kraków, IGSMiE PAN, 2017, p. 91.
25. A. Lempart, E. Kudlek, M. Dudziak, The Occurrence of Micropollutants from PPCPs Macro Group in Swimming Pool Water, Central European Conference ECOpole’17, 4–7 October, Abstracts, 2017, p. 25.
26. E.J. van den Brandhof, M. Montforts, Fish embryo toxicity of carbamazepine, diclofenac and metoprolol, Ecotoxicol. Environ. Saf., 73 (2010) 1862–1866.
27. G.V. Aguirre-Martínez. S. Buratti, E. Fabbr, A.T. DelValls, M.L. Martín-Díaz, Using lysosomal membrane stability of haemocytes in Ruditapes philippinarum as a biomarker of cellular stress to assess contamination by caffeine, ibuprofen, carbamazepine and novobiocin, J. Environ. Sci. (China), 25 (2013) 1408–1418.
28. A. Bahlmann, J.J. Carvalho, M.G. Weller, U. Panne, R.J. Schneider, Immunoassays as high-throughput tools: monitoring spatial and temporal variations of carbamazepine, caffeine and cetirizine in surface and wastewaters, Chemosphere, 89 (2012) 1278–1286.
29. H. Chen, J. Zha, X. Liang, Z. Wang, Effects of the human antiepileptic drug carbamazepine on the behavior, biomarkers, and heat shock proteins in the Asian clam Corbicula fluminea, Aquat. Toxicol., 155 (2014) 1–8.
30. A. Kacperska, Plant Responses to Abiotic Stressors, J. Kopcewicz, S. Lewak, Eds., Plant Physiology, PWN, Warszawa, 2002, pp. 612–678 (in Polish).
31. Z.H. Li, P. Li, M. Rodina, T. Randak, Effect of human pharmaceutical carbamazepine on the quality parameters and oxidative stress in common carp (Cyprinus carpio L.) spermatozoa, Chemosphere, 80 (2010) 530–534.
32. G.K. McEvoy, Ed., AHFS Drug Information, in: Benzocaine, American Society of Health-System Pharmacists, Bethesda, 2007, pp. 2844–2845.
33. United States Food and Drug Administration, Life- Threatening Side Effects with the Use of Skin Products Containing Numbing Ingredients for Cosmetic Procedures: Public Health Advisory, 2007. Available at: https://wayback.archive-it.org/7993/20170723000353/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm054718.htm.
34. J.R. Shua-Haim, J.S. Gross, Methemoglobinemia toxicity from topical benzocaine spray, J. Am. Geriatr. Soc., 43 (1995) 590.
35. A.J. González-Rodríguez, E.M. Gutiérrez-Paredes, Á. Revert Fernández, E. Jordá-Cuevas, Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results, Actas Dermosifiliogr., 104 (2013) 156–158.
36. A. Jagoda, W. Żukowski, B. Dąbrowska, Investigations of the presence of caffeine in the Rudawa River, Kraków, Poland, Environ. Monit. Assess., 187 (2015) 566.
37. J. Wu, J. Yue, R. Hu, Use of Caffeine and human pharmaceutical compounds to identify sewage contamination, Int. J. Environ. Eng., 2 (2010) 98–102.
38. DIN 19643, Aufbereitung von Schwimm und Badebeckenwasser, Dusseldorf, 1997.
39. Regulation of the Minister of Health of 9 November 2015 on the Requirements for Water in the Swimming Pools, Journal of Laws of the Republic of Poland No 2015 item 2016 (in polish).
40. R. Seiler, S.D. Zaugg, J.M. Thomas, D.L. Howcroft, Caffeine and pharmaceuticals as indicators of waste water contamination in wells, Groundwater, 37 (1999) 405–410.
41. J. Wyczarska-Kokot, A. Lempart, M. Dudziak, Chlorine Contamination in Different Points of Pool - Risk Analysis for Bather Health, Central European Conference ECOpole’17, 2017, pp. 41–42.
42. F. Piechurski, Which system pays off? part 1 - Conditions for the design of pool water circulation installations (in Polish: Jaki system się opłaca cz. 1 – Warunki projektowania instalacji cyrkulacji wody basenowej), Pływalnie i baseny, 7 (2011) 88–95.